OnKure Therapeutics, Inc. OKUR Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by OnKure Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: OnKure Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about OnKure Therapeutics, Inc.'s operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is OnKure Therapeutics, Inc.'s operating cash flow?
- OnKure Therapeutics, Inc. (OKUR) reported operating cash flow of -$12.94M in Q1 2026.
- How has OnKure Therapeutics, Inc.'s operating cash flow changed year-over-year?
- OnKure Therapeutics, Inc.'s operating cash flow increased by 7.6% year-over-year, from -$14.01M to -$12.94M.
- What is the long-term trend for OnKure Therapeutics, Inc.'s operating cash flow?
- Over 3 years (2021 to 2025), OnKure Therapeutics, Inc.'s operating cash flow has grown at a 10.9% compound annual growth rate (CAGR), from -$37.98M to -$51.83M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.